Published in Hepatitis Weekly, July 7th, 2003
According to published research from France, "a randomized, open-label trial was performed to study virological and intracellular interactions between stavudine and ribavirin in 30 patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)."
"Patients were randomized to receive either interferon and ribavirin or no treatment for HCV infection for three months," and "intracellular peripheral blood mononuclear cells' stavudine-triphosphate (TP) concentrations were assessed" during this time, noted D....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly